- Controversies Regarding the Value of Estimated Glomerular Filtration Rate to Identify and Monitor Chronic Kidney Disease

- Acute Phosphate Nephropathy

- The Role of Tolvaptan, a New Selective V2R Antagonist, in the Management of Hyponatremia in Patients with Cirrhosis, Heart Failure, or SIADH

Chapter 48. Hemodialysis and Peritoneal Dialysis

Chapter 51. Drug Therapy Individualization for Patients with Renal Insufficiency

Chapter 45. Acute Renal Failure:

- Pharmacologic Therapies

- Pharmacologic

Chapter 46. Chronic Kidney Disease: Progression-Modifying Therapies:

- Pharmacologic Therapy

- Treatment: Diabetic Chronic Kidney Disease

- Treatment: Nondiabetic Chronic Kidney Disease

Chapter 47. Chronic Kidney Disease: Management of Complications:

- Treatment: Chronic Kidney Disease

Chapter 49. Drug-Induced Kidney Disease:

- Aminoglycoside Nephrotoxicity > Management

- Cisplatin and Carboplatin Nephrotoxicity > Management

- Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers > Management

Chapter 50. Glomerulonephritis:

- Treatment: Glomerulonephritis

- Treatment: Minimal-Change Nephropathy

- Treatment: Focal Segmental Glomerulosclerosis

- Treatment: Membranous Nephropathy

- Treatment: Membranoproliferative Glomerulonephritis

- Treatment: Immunoglobulin A Nephropathy

- Treatment: Lupus Nephritis

- Treatment: Rapidly Progressive Glomerulonephritis

- Treatment: Poststreptococcal Glomerulonephritis

Chapter 53. Disorders of Calcium and Phosphorus Homeostasis:

- Sidebar: Clinical Controversy > Pharmacologic Therapy

- Treatment: Hypocalcemia > Pharmacologic Therapy

Chapter 147. Nutritional Considerations in Major Organ Failure:

- Treatment: Acute Renal Failure > Pharmacologic Therapies

- Treatment: Chronic Kidney Disease > Pharmacologic Therapies

- Are We ON TARGET with Dual RAS Blockade?

Chapter 42. Agents that Affect Bone Mineral Homeostasis:

- Idiopathic Hypercalciuria

Chapter 46. Fluid and Electrolyte Disturbances:

- Hypovolemia: Treatment

- Hyponatremia: Treatment

- Hypernatremia: Treatment

- Hypokalemia: Treatment

- Hyperkalemia: Treatment

Chapter 47. Hypercalcemia and Hypocalcemia:

- Hypercalcemia: Treatment

- Hypocalcemia: Treatment

Chapter 48. Acidosis and Alkalosis:

- Metabolic Acidosis: Treatment

- Alcoholic Ketoacidosis: Treatment

- Induced Acidosis: Treatment

- Alcohol-Induced Acidosis: Treatment

- Renal Failure: Treatment

- Metabolic Alkalosis: Treatment

Chapter 90. Bladder and Renal Cell Carcinomas:

- Renal Cell Carcinoma: Treatment

Chapter 270. Oncologic Emergencies:

- Tumor Lysis Syndrome: Treatment

Chapter 273. Acute Renal Failure:

- Acute Renal Failure: Treatment

Chapter 274. Chronic Kidney Disease:

- Chronic Kidney Disease: Treatment

Chapter 278. Polycystic Kidney Disease and Other Inherited Tubular Disorders:

- Autosomal Dominant Polycystic Kidney Disease: Treatment

- Cystinuria: Treatment

Chapter 280. Vascular Injury to the Kidney:

- Scleroderma: Treatment

- Renal Vein Thrombosis: Treatment

Chapter 281. Nephrolithiasis:

- Evaluation and Treatment of Patients with Nephrolithiasis

Chapter 347. Diseases of the Parathyroid Gland and Other Hyper- and Hypocalcemic Disorders:

- Chronic Renal Failure: Treatment

Chapter 90. Bladder and Renal Cell Carcinomas:

- The most common symptom is painless gross hematuria, and the disease is usually detected on...

Chapter 161. Antimycobacterial Agents:

- Table 161-1 Use of First-Line Antimycobacterial Agents in Patients with Renal or Hepatic Disease and in Pregnant Women